技术与方法 |
|
|
|
|
一种多肽固相合成方法与纯化策略研究 |
王宇航,陈学明,刘俗生,阮志军,张敏,宋春丽,尹丰*(),李子刚*() |
深圳湾实验室坪山生物医药研发转化中心 深圳 518118 |
|
A Solid-phase Synthesis Method and Purification of Polypeptides |
WANG Yu-hang,CHEN Xue-ming,LIU Su-sheng,RUAN Zhi-jun,ZHANG Min,SONG Chun-li,YIN Feng*(),LI Zi-gang*() |
Shenzhen Bay Laboratory Pingshan Translational Medicine Center, Shenzhen 518118, China |
引用本文:
王宇航, 陈学明, 刘俗生, 阮志军, 张敏, 宋春丽, 尹丰, 李子刚. 一种多肽固相合成方法与纯化策略研究[J]. 中国生物工程杂志, 2023, 43(1): 35-41.
WANG Yu-hang, CHEN Xue-ming, LIU Su-sheng, RUAN Zhi-jun, ZHANG Min, SONG Chun-li, YIN Feng, LI Zi-gang. A Solid-phase Synthesis Method and Purification of Polypeptides. China Biotechnology, 2023, 43(1): 35-41.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2209002
或
https://manu60.magtech.com.cn/biotech/CN/Y2023/V43/I1/35
|
[1] |
Bruno B J, Miller G D, Lim C S. Basics and recent advances in peptide and protein drug delivery. Therapeutic Delivery, 2013, 4(11): 1443-1467.
doi: 10.4155/tde.13.104
pmid: 24228993
|
[2] |
Brauer F, Schmidt K, Zahn R C, et al. A rationally engineered anti-HIV peptide fusion inhibitor with greatly reduced immunogenicity. Antimicrobial Agents and Chemotherapy, 2013, 57(2): 679-688.
doi: 10.1128/AAC.01152-12
pmid: 23147734
|
[3] |
张伟, 宋竟婧, 张邦治, 等. 多肽新药研发策略研究进展. 中国科学: 化学, 2013, 43(8): 941-952.
|
|
Zhang W, Song J J, Zhang B Z, et al. Advances in the strategies for the development of novel peptide drugs. Scientia Sinica (Chimica), 2013, 43(8): 941-952.
|
[4] |
王德心. 活性多肽与药物开发. 北京: 中国医药科技出版社, 2008: 6-26.
|
|
Wang D X. Peptides and drug development. Beijing: China Medical Science Press, 2008: 6-26.
|
[5] |
厉保秋. 多肽药物研究与开发. 北京: 人民卫生出版社, 2011: 3-50.
|
|
Li B Q. Peptide drugs research and development. Beijing: People’s Medical Publishing House, 2011: 3-50.
|
[6] |
Eggink D, Bontjer I, de Taeye S W, et al. HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry. Journal of Biological Chemistry, 2019, 294(15): 5736-5746.
doi: 10.1074/jbc.RA119.007360
pmid: 30696772
|
[7] |
徐君, 周长林, 窦洁. 抗病毒多肽药物的研究进展. 药物生物技术, 2017, 24(3): 249-254.
|
|
Xu J, Zhou C L, Dou J. The research progress of antiviral peptides. Pharmaceutical Biotechnology, 2017, 24(3): 249-254.
|
[8] |
马春喜, 宋可可, 胡娇, 等. 多肽在流感病毒研究中的应用. 中国家禽, 2018, 40(24): 39-44.
|
|
Ma C X, Song K K, Hu J, et al. Applications of the peptides in the research of influenza virus. China Poultry, 2018, 40(24): 39-44.
|
[9] |
胡玉玺, 蒋煜, 韩天娇. 制备工艺和过程控制对合成多肽药物有关物质的影响. 中国新药杂志, 2017, 26(18): 2143-2148.
|
|
Hu Y X, Jiang Y, Han T J. Effects of manufacturing process and process control on related substances of synthetic peptide drugs. Chinese Journal of New Drugs, 2017, 26(18): 2143-2148.
|
[10] |
王克全, 徐寒梅. 多肽类药物的研究进展. 药学进展, 2015, 39(9): 642-650.
|
|
Wang K Q, Xu H M. Advances in research on polypeptide drugs. Progress in Pharmaceutical Sciences, 2015, 39(9): 642-650.
|
[11] |
孙立春, Coy D H. 多肽药物研究进展. 上海医药, 2014, 35(5): 55-60.
|
|
Sun L C, Coy D H. The development in peptide-based drugs. Shanghai Medical & Pharmaceutical Journal, 2014, 35(5): 55-60.
|
[12] |
唐宏琨. 减肥多肽JFT的固相合成及纯化制备工艺研究. 西安: 西北大学, 2007.
|
|
Tang H K. Studies on solid-phase synthesis, purification and preparation of peptide JFT. Xi’an: Northwest University, 2007.
|
[13] |
Erak M, Bellmann-Sickert K, Els-Heindl S, et al. Peptide chemistry toolbox -transforming natural peptides into peptide therapeutics. Bioorganic & Medicinal Chemistry, 2018, 26(10): 2759-2765.
doi: 10.1016/j.bmc.2018.01.012
|
[14] |
Lawrenson S B, Arav R, North M. The greening of peptide synthesis. Green Chemistry, 2017, 19(7): 1685-1691.
doi: 10.1039/C7GC00247E
|
[15] |
郑龙, 田佳鑫, 张泽鹏, 等. 多肽药物制备工艺研究进展. 化工学报, 2021, 72(7): 3538-3550.
|
|
Zheng L, Tian J X, Zhang Z P, et al. Progress on pharmaceutical engineering of peptide-based drugs. CIESC Journal, 2021, 72(7): 3538-3550.
|
[16] |
孙李丹, 黄嬛. 基于基金项目的药学创新实验设计——以“Fmoc固相合成多肽”为例. 嘉兴学院学报, 2019, 31(6): 136-141.
|
|
Sun L D, Huang X. An experiment design of pharmacy innovation based on a funded project-a case study on “fmoc solid phase peptide synthesis”. Journal of Jiaxing University, 2019, 31(6): 136-141.
|
[17] |
Chan W C, White P D. Fmoc solid phase and peptide synthesis. Oxford: Oxford University Presee, 2000: 170-190.
|
[18] |
黄蓓. 多肽固相合成研究进展. 河南化工, 2013, 30(1): 28-30, 58.
|
|
Huang B. Research progress of solid phase peptide synthesis. Henan Chemical Industry, 2013, 30(1): 28-30, 58.
|
[19] |
韩香, 顾军. 固相法在多肽合成领域的应用. 药学进展, 2004, 28(1): 10-14.
|
|
Han X, Gu J. Application of solid-phase peptides synthesis. Progress in Pharmaceutical Sciences, 2004, 28(1): 10-14.
|
[20] |
曲朋, 宋利, 赵好冬, 等. 多肽合成研究进展. 中国现代中药, 2015, 17(3): 285-289, 295.
|
|
Qu P, Song L, Zhao H D, et al. Research progress of peptide synthesis. Modern Chinese Medicine, 2015, 17(3): 285-289, 295.
|
[21] |
刘杰, 高晨昊, 甘一如, 等. FMOC新型固相法合成胸腺素α1及其反应途径. 天津药学, 2001, 13(3): 39-41.
|
|
Liu J, Gao C H, Gan Y R, et al. Synthesis of thymic α 1 and its reaction pathway by Fmoc novel solid-phase method. Tianjin Pharmacy, 2001, 13(3): 39-41.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|